Stress urinary incontinence (SUI) is a common and debilitating problem for many women, particularly after childbirth or in later years. 

Yet, despite this, treatment options are limited, held back by a lack of research into medical products focused on women’s health. 

Versameb, hopes to change this with a novel mRNA therapy that rebuilds the urinary sphincter and is about to enter clinical trials. In this podcast, Richard Staines from Optimum Strategic Communications caught up with the Versameb team to find out more. Read the insight piece here: Versameb: Revolutionizing SUI therapy with mRNA technology

https://www.optimumcomms.com/podcast / https://versameb.com/

Follow us and subscribe for new episodes highlighting the latest innovation and developments in life sciences, with industry leaders of the healthcare sector.

Available on all major platforms: Apple, Spotify, Google, Amazon Music, Tune In, Castbox, Deezer and more! 

Follow and Subscribe today. #optimumperspectivespodcast

Hosted on Acast. See acast.com/privacy for more information.